LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 9 of total 9

Search options

  1. Article ; Online: Alleviating Hypertension by Selectively Targeting Angiotensin Receptor-Expressing Vagal Sensory Neurons.

    Baumer-Harrison, Caitlin / Elsaafien, Khalid / Johnson, Dominique N / Peñaloza Aponte, Jesus D / de Araujo, Alan / Patel, Sagar / Bruce, Erin B / Harden, Scott W / Frazier, Charles J / Scott, Karen A / de Lartigue, Guillaume / Krause, Eric G / de Kloet, Annette D

    The Journal of neuroscience : the official journal of the Society for Neuroscience

    2024  Volume 44, Issue 9

    Abstract: Cardiovascular homeostasis is maintained, in part, by neural signals arising from arterial baroreceptors that apprise the brain of blood volume and pressure. Here, we test whether neurons within the nodose ganglia that express angiotensin type-1a ... ...

    Abstract Cardiovascular homeostasis is maintained, in part, by neural signals arising from arterial baroreceptors that apprise the brain of blood volume and pressure. Here, we test whether neurons within the nodose ganglia that express angiotensin type-1a receptors (referred to as NG
    MeSH term(s) Mice ; Male ; Female ; Animals ; Desoxycorticosterone Acetate/pharmacology ; Hypertension ; Solitary Nucleus/physiology ; Sensory Receptor Cells ; Blood Pressure/physiology ; Phenylephrine/pharmacology ; Ion Channels ; Red Fluorescent Protein
    Chemical Substances tdTomato ; Desoxycorticosterone Acetate (6E0A168OB8) ; Phenylephrine (1WS297W6MV) ; Piezo1 protein, mouse ; Ion Channels ; Red Fluorescent Protein
    Language English
    Publishing date 2024-02-28
    Publishing country United States
    Document type Journal Article
    ZDB-ID 604637-x
    ISSN 1529-2401 ; 0270-6474
    ISSN (online) 1529-2401
    ISSN 0270-6474
    DOI 10.1523/JNEUROSCI.1154-23.2023
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: The intricacies of the renin-angiotensin-system in metabolic regulation.

    Bruce, Erin B / de Kloet, Annette D

    Physiology & behavior

    2017  Volume 178, Page(s) 157–165

    Abstract: Over recent years, the renin-angiotensin-system (RAS), which is best-known as an endocrine system with established roles in hydromineral balance and blood pressure control, has emerged as a fundamental regulator of many additional physiological and ... ...

    Abstract Over recent years, the renin-angiotensin-system (RAS), which is best-known as an endocrine system with established roles in hydromineral balance and blood pressure control, has emerged as a fundamental regulator of many additional physiological and pathophysiological processes. In this manuscript, we celebrate and honor Randall Sakai's commitment to his trainees, as well as his contribution to science. Scientifically, Randall made many notable contributions to the recognition of the RAS's roles in brain and behavior. His interests, in this regard, ranged from its traditionally-accepted roles in hydromineral balance, to its less-appreciated functions in stress responses and energy metabolism. Here we review the current understanding of the role of the RAS in the regulation of metabolism. In particular, the opposing actions of the RAS within adipose tissue vs. its actions within the brain are discussed.
    Language English
    Publishing date 2017-09-01
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 3907-x
    ISSN 1873-507X ; 0031-9384
    ISSN (online) 1873-507X
    ISSN 0031-9384
    DOI 10.1016/j.physbeh.2016.11.020
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: The intricacies of the renin-angiotensin-system in metabolic regulation

    Bruce, Erin B / de Kloet, Annette D

    Physiology & behavior. 2017 Sept. 01, v. 178

    2017  

    Abstract: Over recent years, the renin-angiotensin-system (RAS), which is best-known as an endocrine system with established roles in hydromineral balance and blood pressure control, has emerged as a fundamental regulator of many additional physiological and ... ...

    Abstract Over recent years, the renin-angiotensin-system (RAS), which is best-known as an endocrine system with established roles in hydromineral balance and blood pressure control, has emerged as a fundamental regulator of many additional physiological and pathophysiological processes. In this manuscript, we celebrate and honor Randall Sakai's commitment to his trainees, as well as his contribution to science. Scientifically, Randall made many notable contributions to the recognition of the RAS's roles in brain and behavior. His interests, in this regard, ranged from its traditionally-accepted roles in hydromineral balance, to its less-appreciated functions in stress responses and energy metabolism. Here we review the current understanding of the role of the RAS in the regulation of metabolism. In particular, the opposing actions of the RAS within adipose tissue vs. its actions within the brain are discussed.
    Keywords adipose tissue ; blood pressure ; brain ; endocrine system ; energy metabolism ; renin-angiotensin system ; stress response
    Language English
    Dates of publication 2017-0901
    Size p. 157-165.
    Publishing place Elsevier Inc.
    Document type Article
    ZDB-ID 3907-x
    ISSN 1873-507X ; 0031-9384
    ISSN (online) 1873-507X
    ISSN 0031-9384
    DOI 10.1016/j.physbeh.2016.11.020
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  4. Article ; Online: ACE2 activator diminazene aceturate reduces adiposity but preserves lean mass in young and old rats.

    Bruce, Erin B / Sakarya, Yasemin / Kirichenko, Nataliya / Toklu, Hale Z / Sumners, Colin / Morgan, Drake / Tümer, Nihal / Scarpace, Philip J / Carter, Christy S

    Experimental gerontology

    2018  Volume 111, Page(s) 133–140

    Abstract: The obesity epidemic is multi-generational and is particularly debilitating in the aging population, necessitating the use of pharmaceutical interventions. Recent evidence suggests that increasing the activity of the angiotensin converting enzyme-2 [ACE2] ...

    Abstract The obesity epidemic is multi-generational and is particularly debilitating in the aging population, necessitating the use of pharmaceutical interventions. Recent evidence suggests that increasing the activity of the angiotensin converting enzyme-2 [ACE2]/angiotensin-(1-7)[Ang-(1-7)]/Mas receptor (MasR) axis in obese animal models leads to significant reductions in body weight. It was hypothesized that activation of ACE2 via diminazene aceturate (DIZE) will significantly reduce body weight of rats fed a high fat diet. Young and old (4 and 23 months, respectively) male Fisher 344 × Brown Norway rats were fed 60% high fat diet for one week, and subsequently given either 15 mg/kg/day DIZE s.c. or vehicle for three weeks. DIZE treatment resulted in a significant reduction of food intake and body weight in both young and old animals. However, that decrease was so dramatic in the older animals that they all nearly stopped eating. Interestingly, the TD-NMR assessments revealed that the weight-loss was primarily a result of decreased body fat percentage, with a relative preservation of lean mass. Tissue weights confirm the significant loss of white adipose tissue (WAT), with no change in muscle weights. Gene expression and serum ACE2 activity analyses implied that increased activation of the ACE2/Ang-(1-7)/MasR axis plays a role in reducing fat mass. Collectively, our results suggest that DIZE may be a useful tool in the study of obesity; however, caution is recommended when using this compound in older animals due to severe anorectic effects, although there is a mechanism by which muscle is preserved.
    MeSH term(s) Adiposity/drug effects ; Age Factors ; Angiotensin I/genetics ; Angiotensin I/metabolism ; Animals ; Diminazene/analogs & derivatives ; Diminazene/pharmacology ; Disease Models, Animal ; Gene Expression ; Male ; Obesity/metabolism ; Peptide Fragments/genetics ; Peptide Fragments/metabolism ; Peptidyl-Dipeptidase A/blood ; Peptidyl-Dipeptidase A/genetics ; Peptidyl-Dipeptidase A/metabolism ; Rats ; Rats, Inbred F344 ; Renin-Angiotensin System/drug effects
    Chemical Substances Peptide Fragments ; Angiotensin I (9041-90-1) ; Peptidyl-Dipeptidase A (EC 3.4.15.1) ; angiotensin converting enzyme 2 (EC 3.4.17.-) ; angiotensin I (1-7) (IJ3FUK8MOF) ; diminazene aceturate (JI8SAD85NO) ; Diminazene (Y5G36EEA5Z)
    Language English
    Publishing date 2018-07-11
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 390992-x
    ISSN 1873-6815 ; 0531-5565
    ISSN (online) 1873-6815
    ISSN 0531-5565
    DOI 10.1016/j.exger.2018.07.008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Drugs, exercise, and the melanocortin-4 receptor-- different means, same ends: treating obesity.

    Schaub, Jay W / Bruce, Erin B / Haskell-Luevano, Carrie

    Advances in experimental medicine and biology

    2010  Volume 681, Page(s) 49–60

    Abstract: As the percentage of obese humans expands, new options for weight loss are being explored. Body weight homeostasis is the result of a balance between energy intake (food) and expenditure (activity). A shift in homeostasis into a negative balance results ... ...

    Abstract As the percentage of obese humans expands, new options for weight loss are being explored. Body weight homeostasis is the result of a balance between energy intake (food) and expenditure (activity). A shift in homeostasis into a negative balance results in weight loss. Two potential options available for the management of body weight, as related to the melanocortin system, are exercise (increase energy expenditure) and drugs targeting the melanocortin-4 receptors for satiety.
    MeSH term(s) Animals ; Exercise/physiology ; Humans ; Melanocortins/metabolism ; Obesity/drug therapy ; Obesity/metabolism ; Obesity/physiopathology ; Receptor, Melanocortin, Type 4/metabolism
    Chemical Substances Melanocortins ; Receptor, Melanocortin, Type 4
    Language English
    Publishing date 2010
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ISSN 2214-8019 ; 0065-2598
    ISSN (online) 2214-8019
    ISSN 0065-2598
    DOI 10.1007/978-1-4419-6354-3_4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Intracerebroventricular tempol administration in older rats reduces oxidative stress in the hypothalamus but does not change STAT3 signalling or SIRT1/AMPK pathway.

    Toklu, Hale Z / Scarpace, Philip J / Sakarya, Yasemin / Kirichenko, Nataliya / Matheny, Michael / Bruce, Erin B / Carter, Christy S / Morgan, Drake / Tümer, Nihal

    Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme

    2017  Volume 42, Issue 1, Page(s) 59–67

    Abstract: Hypothalamic inflammation and increased oxidative stress are believed to be mechanisms that contribute to obesity. 4-Hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl (tempol), a free radical scavenger, has been shown to reduce inflammation and oxidative ... ...

    Abstract Hypothalamic inflammation and increased oxidative stress are believed to be mechanisms that contribute to obesity. 4-Hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl (tempol), a free radical scavenger, has been shown to reduce inflammation and oxidative stress. We hypothesized that brain infusion of tempol would reduce oxidative stress, and thus would reduce food intake and body weight and improve body composition in rats with age-related obesity and known elevated oxidative stress. Furthermore, we predicted an associated increase in markers of leptin signalling, including the silent mating type information regulator 2 homolog 1 (SIRT1)/5'AMP-activated protein kinase (AMPK) pathway and the signal transducer and activator of transcription 3 (STAT3) pathway. For this purpose, osmotic minipumps were placed in the intracerebroventricular region of young (3 months) and aged (23 months) male Fischer 344 x Brown Norway rats for the continuous infusion of tempol or vehicle for 2 weeks. Tempol significantly decreased (p < 0.01) nicotinamide adenine dinucleotide phosphate oxidase activity in the hypothalamus but failed to reduce food intake or weight gain and did not alter body composition. SIRT1 activity and Acetyl p53 were decreased and phosphorylation of AMPK was increased with age, but they were unchanged with tempol. Basal phosphorylation of STAT3 was unchanged with age or tempol. These results indicate that tempol decreases oxidative stress but fails to alter feeding behaviour, body weight, or body composition. Moreover, tempol does not modulate the SIRT1/AMPK/p53 pathway and does not change leptin signalling. Thus, a reduction in hypothalamic oxidative stress is not sufficient to reverse age-related obesity.
    MeSH term(s) AMP-Activated Protein Kinases/metabolism ; Aging ; Animals ; Cognitive Dysfunction/etiology ; Cognitive Dysfunction/prevention & control ; Crosses, Genetic ; Cyclic N-Oxides/administration & dosage ; Cyclic N-Oxides/adverse effects ; Cyclic N-Oxides/therapeutic use ; Energy Intake/drug effects ; Free Radical Scavengers/administration & dosage ; Free Radical Scavengers/adverse effects ; Free Radical Scavengers/therapeutic use ; Hypothalamus/drug effects ; Hypothalamus/metabolism ; Infusion Pumps, Implantable ; Infusions, Intraventricular ; Male ; Nerve Tissue Proteins/metabolism ; Neurons/drug effects ; Neurons/metabolism ; Nootropic Agents/administration & dosage ; Nootropic Agents/adverse effects ; Nootropic Agents/therapeutic use ; Obesity/drug therapy ; Obesity/physiopathology ; Oxidative Stress/drug effects ; Rats, Inbred BN ; Rats, Inbred F344 ; STAT3 Transcription Factor/metabolism ; Signal Transduction/drug effects ; Sirtuin 1/metabolism ; Spin Labels
    Chemical Substances Cyclic N-Oxides ; Free Radical Scavengers ; Nerve Tissue Proteins ; Nootropic Agents ; STAT3 Transcription Factor ; Spin Labels ; Stat3 protein, rat ; AMP-Activated Protein Kinases (EC 2.7.11.31) ; Sirt1 protein, rat (EC 3.5.1.-) ; Sirtuin 1 (EC 3.5.1.-) ; tempol (U78ZX2F65X)
    Language English
    Publishing date 2017-01
    Publishing country Canada
    Document type Journal Article
    ZDB-ID 2236708-1
    ISSN 1715-5320 ; 1715-5312
    ISSN (online) 1715-5320
    ISSN 1715-5312
    DOI 10.1139/apnm-2016-0067
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Intracerebroventricular tempol administration in older rats reduces oxidative stress in the hypothalamus but does not change STAT3 signalling or SIRT1/AMPK pathway

    Toklu, Hale Z / Scarpace, Philip J / Sakarya, Yasemin / Kirichenko, Nataliya / Matheny, Michael / Bruce, Erin B / Carter, Christy S / Morgan, Drake / Tümer, Nihal

    Applied Physiology, Nutrition, and Metabolism. 2016 Oct. 6, v. 42, no. 1

    2016  

    Abstract: Hypothalamic inflammation and increased oxidative stress are believed to be mechanisms that contribute to obesity. 4-Hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl (tempol), a free radical scavenger, has been shown to reduce inflammation and oxidative ... ...

    Abstract Hypothalamic inflammation and increased oxidative stress are believed to be mechanisms that contribute to obesity. 4-Hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl (tempol), a free radical scavenger, has been shown to reduce inflammation and oxidative stress. We hypothesized that brain infusion of tempol would reduce oxidative stress, and thus would reduce food intake and body weight and improve body composition in rats with age-related obesity and known elevated oxidative stress. Furthermore, we predicted an associated increase in markers of leptin signalling, including the silent mating type information regulator 2 homolog 1 (SIRT1)/5′AMP-activated protein kinase (AMPK) pathway and the signal transducer and activator of transcription 3 (STAT3) pathway. For this purpose, osmotic minipumps were placed in the intracerebroventricular region of young (3 months) and aged (23 months) male Fischer 344 x Brown Norway rats for the continuous infusion of tempol or vehicle for 2 weeks. Tempol significantly decreased (p < 0.01) nicotinamide adenine dinucleotide phosphate oxidase activity in the hypothalamus but failed to reduce food intake or weight gain and did not alter body composition. SIRT1 activity and Acetyl p53 were decreased and phosphorylation of AMPK was increased with age, but they were unchanged with tempol. Basal phosphorylation of STAT3 was unchanged with age or tempol. These results indicate that tempol decreases oxidative stress but fails to alter feeding behaviour, body weight, or body composition. Moreover, tempol does not modulate the SIRT1/AMPK/p53 pathway and does not change leptin signalling. Thus, a reduction in hypothalamic oxidative stress is not sufficient to reverse age-related obesity.
    Keywords NADP (coenzyme) ; Rattus norvegicus ; body composition ; enzyme activity ; feeding behavior ; food intake ; free radical scavengers ; hypothalamus ; inflammation ; leptin ; males ; metabolism ; obesity ; oxidative stress ; phosphorylation ; protein kinases ; rats ; signal transduction ; transactivators ; weight gain
    Language English
    Dates of publication 2016-1006
    Size p. 59-67.
    Publishing place NRC Research Press
    Document type Article
    ZDB-ID 2236708-1
    ISSN 1715-5320 ; 1715-5312
    ISSN (online) 1715-5320
    ISSN 1715-5312
    DOI 10.1139/apnm-2016-0067
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  8. Article ; Online: Coupling corticotropin-releasing-hormone and angiotensin converting enzyme 2 dampens stress responsiveness in male mice.

    Wang, Lei A / de Kloet, Annette D / Smeltzer, Michael D / Cahill, Karlena M / Hiller, Helmut / Bruce, Erin B / Pioquinto, David J / Ludin, Jacob A / Katovich, Michael J / Raizada, Mohan K / Krause, Eric G

    Neuropharmacology

    2018  Volume 133, Page(s) 85–93

    Abstract: This study used mice to evaluate whether coupling expression of corticotropin-releasing hormone (CRH) and angiotensin converting enzyme 2 (ACE2) creates central interactions that blunt endocrine and behavioral responses to psychogenic stress. Central ... ...

    Abstract This study used mice to evaluate whether coupling expression of corticotropin-releasing hormone (CRH) and angiotensin converting enzyme 2 (ACE2) creates central interactions that blunt endocrine and behavioral responses to psychogenic stress. Central administration of diminazene aceturate, an ACE2 activator, had no effect on restraint-induced activation of the hypothalamic-pituitary-adrenal (HPA) axis; however, mice that ubiquitously overexpress ACE2 had reduced plasma corticosterone (CORT) and pituitary expression of POMC mRNA. The Cre-LoxP system was used to restrict ACE2 overexpression to CRH synthesizing cells and probe whether HPA axis suppression was the result of central ACE2 and CRH interactions. Within the paraventricular nucleus of the hypothalamus (PVN), mice with ACE2 overexpression directed to CRH had a ≈2.5 fold increase in ACE2 mRNA, which co-localized with CRH mRNA. Relative to controls, mice overexpressing ACE2 in CRH cells had a decreased CORT response to restraint as well as decreased CRH mRNA in the PVN and CEA and POMC mRNA in the pituitary. Administration of ACTH similarly increased plasma CORT, indicating that the blunted HPA axis activation that accompanies ACE2 overexpression in CRH cells is centrally mediated. Anxiety-like behavior was assessed to determine whether the decreased HPA axis activation was predictive of anxiolysis. Mice with ACE2 overexpression directed to CRH cells displayed decreased anxiety-like behavior in the elevated plus maze and open field when compared to that of controls. Collectively, these results suggest that exogenous ACE2 suppresses CRH synthesis, which alters the central processing of psychogenic stress, thereby blunting HPA axis activation and attenuating anxiety-like behavior.
    MeSH term(s) Adrenocorticotropic Hormone/pharmacology ; Animals ; Anxiety/drug therapy ; Anxiety/etiology ; Corticotropin-Releasing Hormone/blood ; Corticotropin-Releasing Hormone/genetics ; Corticotropin-Releasing Hormone/metabolism ; Corticotropin-Releasing Hormone/therapeutic use ; Diminazene/analogs & derivatives ; Diminazene/therapeutic use ; Disease Models, Animal ; Dose-Response Relationship, Drug ; Enzyme Activators/therapeutic use ; Hormones/pharmacology ; Hypothalamo-Hypophyseal System/drug effects ; Hypothalamo-Hypophyseal System/metabolism ; Injections, Intraventricular ; Male ; Maze Learning/drug effects ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Peptidyl-Dipeptidase A/genetics ; Peptidyl-Dipeptidase A/metabolism ; Pituitary Gland/metabolism ; Pituitary-Adrenal System/diagnostic imaging ; Pituitary-Adrenal System/metabolism ; Pro-Opiomelanocortin/genetics ; Pro-Opiomelanocortin/metabolism ; RNA, Messenger/metabolism ; Stress, Psychological/drug therapy ; Stress, Psychological/genetics ; Stress, Psychological/metabolism
    Chemical Substances Enzyme Activators ; Hormones ; RNA, Messenger ; Pro-Opiomelanocortin (66796-54-1) ; Adrenocorticotropic Hormone (9002-60-2) ; Corticotropin-Releasing Hormone (9015-71-8) ; Peptidyl-Dipeptidase A (EC 3.4.15.1) ; angiotensin converting enzyme 2 (EC 3.4.17.-) ; diminazene aceturate (JI8SAD85NO) ; Diminazene (Y5G36EEA5Z)
    Language English
    Publishing date 2018-01-31
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 218272-5
    ISSN 1873-7064 ; 0028-3908
    ISSN (online) 1873-7064
    ISSN 0028-3908
    DOI 10.1016/j.neuropharm.2018.01.025
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Anorexic response to rapamycin does not appear to involve a central mechanism.

    Toklu, Hale Z / Bruce, Erin B / Sakarya, Yasemin / Carter, Christy S / Morgan, Drake / Matheny, Michael K / Kirichenko, Nataliya / Scarpace, Philip J / Tümer, Nihal

    Clinical and experimental pharmacology & physiology

    2016  Volume 43, Issue 9, Page(s) 802–807

    Abstract: The authors have previously demonstrated that a low and intermittent peripheral dose of rapamycin (1 mg/kg three times/week) to rats inhibited mTORC1 signalling, but avoided the hyperlipidemia and diabetes-like syndrome associated with higher doses of ... ...

    Abstract The authors have previously demonstrated that a low and intermittent peripheral dose of rapamycin (1 mg/kg three times/week) to rats inhibited mTORC1 signalling, but avoided the hyperlipidemia and diabetes-like syndrome associated with higher doses of rapamycin. The dosing regimen reduced food intake, body weight, adiposity, serum leptin and triglycerides. mTORC1 signalling was inhibited in both liver and hypothalamus, suggesting some of the actions, in particular the decrease in food intake, may be the results of a central mechanism. To test this hypothesis, rapamycin (30 μg/day for 4 weeks) was infused into 23-25-month-old F344xBN rats by intracerebroventricular (icv) mini pumps. Our results demonstrated that central infusion did not alter food intake or body weight, although there was a tendency for a decrease in body weight towards the end of the study. mTORC1 signalling, evidenced by decreased phosphorylation of S6 protein at end of 4 weeks, was not activated in liver, hypothalamus or hindbrain. Fat and lean mass, sum of white adipose tissues, brown adipose tissue, serum glucose, insulin and leptin levels remained unchanged. Thus, these data suggest that the anorexic and body weight responses evident with peripheral rapamycin are not the result of direct central action. The tendency for decreased body weight towards the end of study, suggests that there is either a slow transport of centrally administered rapamycin into the periphery, or that there is delayed action of rapamycin at sites in the brain.
    MeSH term(s) Animals ; Anorexia/drug therapy ; Anorexia/metabolism ; Anorexia/physiopathology ; Body Weight/drug effects ; Eating/drug effects ; Energy Intake/drug effects ; Rats ; Sirolimus/pharmacology ; Sirolimus/therapeutic use ; Treatment Outcome
    Chemical Substances Sirolimus (W36ZG6FT64)
    Language English
    Publishing date 2016-09-27
    Publishing country Australia
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 189277-0
    ISSN 1440-1681 ; 0305-1870 ; 0143-9294
    ISSN (online) 1440-1681
    ISSN 0305-1870 ; 0143-9294
    DOI 10.1111/1440-1681.12601
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top